Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS

Security class unavailable · CUSIP: 10501E201

Event date: 2023-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,660,000
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-041961
Form type
SC 13G/A
Filer
BRAINSTORM CELL THERAPEUTICS INC.
CIK
CIK 1137883
Filed
Apr 05, 2023
Reporting period
Mar 17, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub